Company Profile
ApicHope Pharmaceutical researches, develops, produces, and sells pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao'er kechuanling oral liquid products
Clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drops, montelukast sodium oral granules, oseltamivir phosphate capsules, and levocetirizine dihydrochloride oral drops
Chronic disease drugs, including aciclovir for injection, hepatocyte growth-promoting factor for injection, pentoxifylline injection, kangshen and niaoqingshu granules, shenbo lotion, compound monoammonium glycyrrhizinate s and lansoprazole for injection, omeprazole sodium for injection, and products. Additionally, it offers compound elsholtzia liquid, yinhuang oral liquid, and xiongdan chuanbei oral liquid products
Levofloxacin hydrochloride for injection, ketorolac trometamol injection, phloroglucinol injection, ibuprofen tablets, vidarabine monophosphate for injection, lexofloxacin tablets, tranexamic acid injection, ropivacaine hydrochloride injection, mecobalamin injection, linezolid for oral suspension, clindamyxin hydrochloride for injection, caspofungin acetate for injection, and tongxuan lifei tablets
Scientific research and technical services. Its portfolio also includes wholesale and retail trade, information technology, and technology promotion and application services. Founded in 2002 and headquartered in Guangzhou, China, ApicHope Pharmaceutical was formerly known as ApicHope Pharmaceutical Co., Ltd before rebranding in December 2024.